Registration Page 

Data Processing Consent
October 2024 - PM-SA-BEX-WCNT-240004
For Healthcare Professionals Only

For more information, please refer to the prescribing information or contact GSK: P.O Box 55850, Jeddah, 21544, Kingdom of Saudi Arabia. Telephone: +966 12 653 6666 or via gcc.medinfo@gsk.com
To report Adverse Event/s associated with the use of GSK product/s, please contact us via saudi.safety@gsk.com
To report Quality related product complaint/s associated with the use of GSK product/s, please contact us via ksa.productqualitycomplaint@gsk.com

Trademarks are owned by or licensed to the GSK group of companies. ©2024 GSK group of companies or its licensor.

I confirm that I'm Healthcare Professional in Saudi Arabia

I confirm that I read and understood the privacy statement https://privacy.gsk.comlen­xg/privacy-notice/healthcare-professionall'

We are committed to respect the SFDA Disclosure and Transparency Initiative UGuide #65925U (The Guide), which requires transparency with regards to financial relationships between Pharmaceutical /medical firms and health care professionals (HCPs) as well as healthcare institutions (HCls) operating in Kingdom of Saudi Arabia. To meet these requirements, GSK must disclose any transfer of value I service provided by GSK to HCPs/HCls to the SFDA while also adhering to the applicable privacy regulations in the Kingdom of Saudi Arabia.'

I here by acknowledge that my information provided will be shared with GSK for the purpose of SFDA disclosure, and Elite Way and its affiliates may use your personal information, including your name, title, organization, photograph, for informational purposes related to the conference/event. This includes but is not limited personal information will be used solely for conference-related purposes and will not be shared with third party purposes without your consent.
I Agree and Give Consent